Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A comprehensive review on metabolic syndrome.

Kaur J.

Cardiol Res Pract. 2014;2014:943162. doi: 10.1155/2014/943162. Epub 2014 Mar 11. Review.

2.

Error occurred: cannot get document summary

PMID:
27753812

3.

The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.

López-Jaramillo P, Gómez-Arbeláez D, López-López J, López-López C, Martínez-Ortega J, Gómez-Rodríguez A, Triana-Cubillos S.

Horm Mol Biol Clin Investig. 2014 Apr;18(1):37-45. doi: 10.1515/hmbci-2013-0053. Review.

4.

Vascular biology of metabolic syndrome.

Vykoukal D, Davies MG.

J Vasc Surg. 2011 Sep;54(3):819-31. doi: 10.1016/j.jvs.2011.01.003. Epub 2011 Mar 24. Review.

5.

The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.

Masquio DC, de Piano A, Campos RM, Sanches PL, Carnier J, Corgosinho FC, Netto BD, Carvalho-Ferreira JP, Oyama LM, Nascimento CM, de Mello MT, Tufik S, Dâmaso AR.

Br J Nutr. 2015 Jun 28;113(12):1920-30. doi: 10.1017/S0007114515001129. Epub 2015 Apr 24.

PMID:
25907896
6.

The role of adipocytokines and neurohormonal dysregulation in metabolic syndrome.

Kong AP, Chan NN, Chan JC.

Curr Diabetes Rev. 2006 Nov;2(4):397-407. Review.

PMID:
18220644
7.

Lifestyle modification and endothelial function in obese subjects.

Hamdy O.

Expert Rev Cardiovasc Ther. 2005 Mar;3(2):231-41. Review.

PMID:
15853597
9.

Review article: adipocytokines and insulin resistance.

Vettor R, Milan G, Rossato M, Federspil G.

Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:3-10. Review.

10.

Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.

Ercin CN, Dogru T, Genc H, Celebi G, Aslan F, Gurel H, Kara M, Sertoglu E, Tapan S, Bagci S, Rizzo M, Sonmez A.

Metab Syndr Relat Disord. 2015 Sep;13(7):319-25. doi: 10.1089/met.2015.0018. Epub 2015 May 26.

PMID:
26011302
11.

Metabolic syndrome: definition and therapeutic implications.

Prasad H, Ryan DA, Celzo MF, Stapleton D.

Postgrad Med. 2012 Jan;124(1):21-30. doi: 10.3810/pgm.2012.01.2514. Review.

PMID:
22314111
12.

The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.

Misra A, Khurana L.

Metab Syndr Relat Disord. 2009 Dec;7(6):497-514. doi: 10.1089/met.2009.0024. Review.

PMID:
19900153
13.

The metabolic syndrome - an ongoing story.

Duvnjak L, Duvnjak M.

J Physiol Pharmacol. 2009 Dec;60 Suppl 7:19-24. Review.

PMID:
20388942
14.

Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.

Aroor AR, McKarns S, Demarco VG, Jia G, Sowers JR.

Metabolism. 2013 Nov;62(11):1543-52. doi: 10.1016/j.metabol.2013.07.001. Epub 2013 Aug 8. Review.

15.

Management issues in the metabolic syndrome.

Deedwania PC, Gupta R.

J Assoc Physicians India. 2006 Oct;54:797-810. Review.

PMID:
17214277
16.

The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.

Reddy KJ, Singh M, Bangit JR, Batsell RR.

J Cardiovasc Med (Hagerstown). 2010 Sep;11(9):633-47. doi: 10.2459/JCM.0b013e328333645a. Review.

PMID:
20164784
18.

The metabolic syndrome: metabolic changes with vascular consequences.

Wassink AM, Olijhoek JK, Visseren FL.

Eur J Clin Invest. 2007 Jan;37(1):8-17.

PMID:
17181562
19.

Metabolic syndrome: therapeutic considerations.

Grundy SM.

Handb Exp Pharmacol. 2005;(170):107-33. Review.

PMID:
16596797
20.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

Supplemental Content

Support Center